Research graph
References from Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET. Local targets link to admitted publications; unresolved targets remain external evidence.
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase development framework
10.1016/j.neurobiolaging.2016.07.012 · 2017 · External reference
Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers
10.1016/s1474-4422(17)30159-x · 2017 · External reference
Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia
10.1016/j.neurobiolaging.2011.09.006 · 2011 · External reference
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
10.1001/jama.2019.2000 · 2019 · External reference
Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project
10.1001/jamaneurol.2018.1346 · 2018 · External reference
Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia
10.1186/s13195-016-0228-4 · 2017 · External reference
AMYPAD Diagnostic and Patient Management Study: Rationale and design
10.1016/j.jalz.2018.09.003 · 2019 · External reference
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial
10.1001/jamaneurol.2023.0997 · 2023 · External reference
Clinical Decision Support in the Era of Artificial Intelligence
10.1001/jama.2018.17163 · 2018 · External reference
Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias
10.1016/s1474-4422(20)30314-8 · 2020 · External reference
The Road to Personalized Medicine in Alzheimer’s Disease: The Use of Artificial Intelligence
10.3390/biomedicines10020315 · 2022 · External reference
Designing the next-generation clinical care pathway for Alzheimer’s disease
10.1038/s43587-022-00269-x · 2022 · External reference
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association
10.1016/j.jalz.2013.01.002 · 2013 · External reference
Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project
10.1016/j.jalz.2019.07.003 · 2019 · External reference
Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care
10.1016/j.dadm.2016.12.001 · 2016 · External reference
Amyloid PET ordering practices in a memory disorders clinic
2022 · External reference
Quantification of amyloid PET for future clinical use: a state-of-the-art review
10.1007/s00259-022-05784-y · 2022 · External reference
Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy
10.1371/journal.pone.0226784 · 2020 · External reference
Optimizing patient care and research: the Amsterdam Dementia Cohort
10.3233/jad-132306 · 2014 · External reference
Amsterdam Dementia Cohort: Performing Research to Optimize Care
10.3233/jad-170850 · 2018 · External reference
Alzheimer’s biomarkers in daily practice (ABIDE) project: Rationale and design
10.1016/j.dadm.2017.01.003 · 2017 · External reference
The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
10.1016/j.jalz.2011.03.005 · 2011 · External reference
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
10.1093/brain/awr179 · 2011 · External reference
Classification of primary progressive aphasia and its variants
10.1212/wnl.0b013e31821103e6 · 2011 · External reference
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
10.1212/wnl.43.2.250 · 1993 · External reference
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
1975 · External reference
Validity of the Trail Making Test as an indicator of organic brain damage
10.2466/pms.1958.8.3.271 · 1958 · External reference
Normative data for the Animal, Profession and Letter M Naming verbal fluency tests for Dutch speaking participants and the effects of age, education, and sex
10.1017/s1355617706060115 · 2006 · External reference
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia
10.1212/wnl.44.12.2308 · 1994 · External reference
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates
10.1136/jnnp.55.10.967 · 1992 · External reference
Automatically computed rating scales from MRI for patients with cognitive disorders
2019 · External reference
Differential diagnosis of neurodegenerative diseases using structural MRI data
10.1016/j.nicl.2016.02.019 · 2016 · External reference
Detecting frontotemporal dementia syndromes using MRI biomarkers
10.1016/j.nicl.2019.101711 · 2019 · External reference
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET
10.1016/j.jalz.2014.07.003 · 2015 · External reference
Quantification of [(18) F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project
2022 · External reference
A disease state fingerprint for evaluation of Alzheimer’s disease
10.3233/jad-2011-110365 · 2011 · External reference
Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study
10.2174/1567205016666190103152425 · 2019 · External reference
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET
10.1016/j.jalz.2018.02.022 · 2018 · External reference
A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume
10.1016/j.neuroimage.2004.06.018 · 2004 · External reference
A MATLAB toolbox for classification and visualization of heterogenous multi-scale human data using the Disease State Fingerprint method
2013 · External reference
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study
2022 · External reference
Machine learning approaches to predicting amyloid status using data from an online research and recruitment registry: The Brain Health Registry
10.1002/dad2.12207 · 2021 · External reference
Accurate risk estimation of beta-amyloid positivity to identify prodromal Alzheimer’s disease: Cross-validation study of practical algorithms
10.1016/j.jalz.2018.08.014 · 2019 · External reference
Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline
10.3389/fnagi.2020.00228 · 2020 · External reference
2023 Alzheimer’s disease facts and figures
10.1002/alz.13016 · 2023 · External reference
Aducanumab: Appropriate Use Recommendations
2021 · External reference
The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey
10.3122/jabfm.2019.06.180328 · 2019 · External reference
The potential clinical value of plasma biomarkers in Alzheimer’s disease
10.1002/alz.13455 · 2023 · External reference
Precision medicine in neurodegeneration: the IHI-PROMINENT project
10.3389/fneur.2023.1175922 · 2023 · External reference
Development and design of a diagnostic report to support communication in dementia: Co-creation with patients and care partners
2022 · External reference
Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier
10.3389/fnagi.2018.00111 · 2018 · External reference
Optimizing cCOG, a Web-based tool, to detect dementia with Lewy Bodies
10.1002/dad2.12379 · 2022 · External reference
